Saul J. Priceman

Dr. Saul Priceman is an Associate Professor in the Department of Medicine at USC, and the Founding Director of the KSOM/Norris Center for Cancer Cellular Immunotherapy Research. Over the last 14 years, his research has focused on T cell immunobiology and cancer immunotherapies. Dr. Priceman’s laboratory develops CAR T cell therapies and combinatorial approaches for the treatment of solid cancers, bringing several therapies to phase 1 clinical testing. His research has led to high-impact publications in Nature Medicine, Nature Biomedical Engineering, Science Translational Medicine, and Nature Communications, with numerous patents and technologies licensed for further clinical development. Dr. Priceman’s research has been funded with grants from the National Cancer Institute, Department of Defense, California Institute for Regenerative Medicine, and the Prostate Cancer Foundation. He received his B.S. in microbiology at UCSB, his Ph.D. in molecular and medical pharmacology at UCLA, and his postdoctoral research at City of Hope.

• Prostate Cancer Foundation: Young Investigator Award, 2015
• National Comprehensive Cancer Network: Young Investigator Award, 2016

• University of California Santa Barbara — BS — 2000 — Microbiology
• California State University Northridge — MS — 2004 — Biology
• University of California Los Angeles — PhD — 2010 — Molecular and Medical Pharmacology
• City of Hope — Postdoctoral Fellowship — 2013 — Cancer Immunotherapy and Tumor Immunology

• Tumor immunology
• Cancer cellular immunotherapy

• Abouelenein, Mohamed
• Wang, Pin
• Wang, Rongfu
• Wang, Yingxiao
• Lenz, Heinz-Josef
• Murad, John